You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Dementias

Citations 51-60 of 116 total displayed.

Past content (since Mar 1998):

Original Contributions
Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care: A Randomized Controlled Trial
Christopher M. Callahan; Malaz A. Boustani; Frederick W. Unverzagt; Mary G. Austrom; Teresa M. Damush; Anthony J. Perkins; Bridget A. Fultz; Siu L. Hui; Steven R. Counsell; Hugh C. Hendrie
JAMA 2006; 295: 2148-2157. [Abstract] [Full text] [PDF] [ Author in the Room Audio ]  

Letters
Atypical Antipsychotic Drugs, Dementia, and Risk of Death
Sudeep S. Gill; Dallas Seitz; Paula A. Rochon
JAMA 2006; 295: 495-a-496-a. [Extract] [Full text] [PDF]  

Letters
Atypical Antipsychotic Drugs, Dementia, and Risk of Death
Harminder Sikand; Joyce Jaojoco; Leslie Linares; Paul S. Phillips
JAMA 2006; 295: 495. [Extract] [Full text] [PDF]  

Letters
Atypical Antipsychotic Drugs, Dementia, and Risk of Death—Reply
Lon S. Schneider; Karen S. Dagerman; Philip Insel
JAMA 2006; 295: 496-a-497-a. [Extract] [Full text] [PDF]  

Letters
Atypical Antipsychotic Drugs, Dementia, and Risk of Death
Karianne Hammerstrøm
JAMA 2006; 295: 496. [Extract] [Full text] [PDF]  

The World in Medicine
Reducing Alzheimer Risk
Joan Stephenson
JAMA 2005; 294: 2423-c. [Extract] [Full text] [PDF]  

Reviews
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia: Meta-analysis of Randomized Placebo-Controlled Trials
Lon S. Schneider; Karen S. Dagerman; Philip Insel
JAMA 2005; 294: 1934-1943. [Abstract] [Full text] [PDF]  

Editorials
Antipsychotic Drugs in Dementia: What Should Be Made of the Risks?
Peter V. Rabins; Constantine G. Lyketsos
JAMA 2005; 294: 1963-1965. [Extract] [Full text] [PDF]  

Letters
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia
Martin Steinberg; Constantine Lyketsos
JAMA 2005; 293: 2211-a-2212-a. [Extract] [Full text] [PDF]  

Letters
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia—Reply
Kaycee M. Sink; Kristine Yaffe
JAMA 2005; 293: 2212-b. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Dementias
 collections from JAMA & Archives Journals.
 •Related collections:
  •Neurology
  •Alzheimer Disease
  •Amyotrophic Lateral Sclerosis
  •Ataxia
  •Behavioral Neurology
  •Cerebrovascular Disease
  •Cognitive Disorders
  •Coma/ Vegetative State
  •Deep Brain Stimulation
  •Dementias
  •Neuroimaging
  •Encephalitis
  •Epilepsy
  •Functional Imaging
  •Neurogenetics
  •Headache
  •Lewy Body Disease
  •Meningitis
  •Migraine
  •Movement Disorders
  •Multiple Sclerosis/ Demyelinating Disease
  •Myasthenia Gravis
  •Neurocutaneous Diseases
  •Neuroendocrinology
  •Neuromuscular diseases
  •Neuro-otology
  •Neuro-ophthalmology
  •Neuropathology
  •Neurotoxicology
  •Parkinson Disease/ Parkinsonian Disorders
  •Pediatric Neurology
  •Stroke
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.